BioNTech
Advancing science to transform cancer and infectious disease treatments
- Headquarters
- Mainz
- Employees
- 5001–10000
- Founded
- 2008
- Business Model
- B2B
- Website
- biontech.com
- Total Funding
- $425.0M
- Last Round
- $425.0M Series AJan 2019
About
BioNTech is a global biotechnology company developing mRNA-based immunotherapies and vaccines for cancer and infectious diseases, leveraging immune engineering to translate science into survival.
Tech Stack
DatabricksDBT
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account